Intratumoural versus circulating lymphoid cells as predictive biomarkers in lung cancer patients treated with immune checkpoint inhibitors: is the easiest path the best one?

Gascón Ruiz, M., Isla, D., Cruellas, M., Galvez, EM.,, Lastra, R., Ocariz-Diez, M.,, Paño-Pardo, JP., Ramírez-Labrada, A., Sesma, A.,,Torres, I., Yubero, A., Pardo, J*., Martinez Lostao, L.* . Intratumoural versus circulating lymphoid cells as predictive biomarkers in lung cancer patients treated with immune checkpoint inhibitors: is the easiest path the best one? Cells, 2020.